4,5-dichlorodithiazol-1-ium chloride - CAS 75318-43-3
Catalog: |
BB035292 |
Product Name: |
4,5-dichlorodithiazol-1-ium chloride |
CAS: |
75318-43-3 |
Synonyms: |
4,5-dichlorodithiazol-1-ium;chloride; 4,5-dichlorodithiazol-1-ium;chloride |
IUPAC Name: | 4,5-dichlorodithiazol-1-ium;chloride |
Description: | 4,5-dichlorodithiazol-1-ium chloride (CAS# 75318-43-3) is a useful research chemical. |
Molecular Weight: | 208.499 |
Molecular Formula: | C2Cl3NS2 |
Canonical SMILES: | C1(=NS[S+]=C1Cl)Cl.[Cl-] |
InChI: | InChI=1S/C2Cl2NS2.ClH/c3-1-2(4)6-7-5-1;/h;1H/q+1;/p-1 |
InChI Key: | NIZMCFUMSHISLW-UHFFFAOYSA-M |
MDL: | MFCD03426194 |
LogP: | -0.20350 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
EP-3658544-A1 | Derivatives of luciferin and methods for their synthesis | 20170725 |
WO-2019021202-A1 | LUCIFERIN DERIVATIVES AND METHODS OF SYNTHESIS | 20170725 |
US-2020331902-A1 | Derivatives of luciferin and methods for their synthesis | 20170725 |
US-11149034-B2 | Derivatives of luciferin and methods for their synthesis | 20170725 |
AU-2018238892-A1 | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound | 20170321 |
PMID | Publication Date | Title | Journal |
22442824 | 20110101 | Synthesis of [(4-chloro-5H-1,2,3-dithiazol-5-ylidene)amino]azines | Molecules (Basel, Switzerland) |
19633609 | 20090702 | The reaction of 4,5-dichloro-1,2,3-dithiazolium chloride with sulfimides: a new synthesis of N-aryl-1,2,3-dithiazolimines | Molecules (Basel, Switzerland) |
12583755 | 20030220 | Novel synthesis and reactions of 5,7-dialkyl-4,6-dioxo-4,5,6,7-tetrahydro- isothiazolo[3,4,-d]pyrimidine-3-carbonitriles and 6-methyl-4-oxo-4H-1-aza-5-oxa-2- thiaindene-3-carbonitrile | Organic letters |
11741793 | 20020201 | Antimicrobial and antitumor activity of N-heteroimmine-1,2,3-dithiazoles and their transformation in triazolo-, imidazo-, and pyrazolopirimidines | Bioorganic & medicinal chemistry |
Complexity: | 70.7 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 206.853774 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 206.853774 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 69.4 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Arenes
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS